This health issue may be early sign of deadly pancreatic cancer

GOT2 and pancreatic cancer: metabolic target and immune A new wave of scientific interest brings to light GOT2 – glutamic-oxaloacetic transaminase 2 – as a... The post GOT2 and pancreatic cancer: metabolic target and immune appeared first on World News.

This health issue may be early sign of deadly pancreatic cancer

Scientists at Boston Medical Center have discovered a surprising connection between gallstones and a deadly type of cancer called pancreatic ductal adenocarcinoma, or PDAC. This type of cancer is the most common form of pancreatic cancer and accounts for over 90% of all cases. What makes PDAC especially dangerous is that it usually isn’t found […] The post This health issue may be early sign of deadly pancreatic cancer appeared first on Knowridg…

Pancreatic cancer is one of the most feared by its silent evolution and high mortality. It is often detected late, when it has already advanced too much, and its resistance to traditional treatments makes it a difficult enemy to overcome. However, a recent Spanish study could open new doors in the fight against this disease, by discovering an hitherto unknown function of a very particular protein: Galectina-1. This finding, led by the Research I…

Study explores reasons behind high aggressiveness of pancreatic cancer

A study by researchers from the Hospital del Mar Research Institute, IIBB-CSIC-IDIBAPS, Mayo Clinic, IBYME (CONICET), and CaixaResearch Institute demonstrates the role of the Galectin-1 protein in the nucleus of the cells surrounding the tumor-fibroblasts-contributing to their activation.